Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 12/3068% below fair value
$5.69+0.07 (+1.25%)
Close on Nov 13, 2026Market cap $151.00MP/E –Yield –
Inogen ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Inogen's ebitda for the twelve months ending Sep 30, 2026 was -$18.49M. For fiscal 2025 it was -$9.55M. The highest annual figure on record is $49.19M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.55M | – |
| FY2024 | Dec 31, 2024 | -$21.51M | – |
| FY2023 | Dec 31, 2023 | -$91.23M | – |
| FY2022 | Dec 31, 2022 | -$61.73M | -300.0% |
| FY2021 | Dec 31, 2021 | $30.87M | +370.8% |
| FY2020 | Dec 31, 2020 | $6.56M | -80.5% |
| FY2019 | Dec 31, 2019 | $33.62M | -31.6% |
| FY2018 | Dec 31, 2018 | $49.19M | +23.3% |
| FY2017 | Dec 31, 2017 | $39.89M | +9.5% |
| FY2016 | Dec 31, 2016 | $36.42M | +25.3% |
| FY2015 | Dec 31, 2015 | $29.06M | +28.6% |
| FY2014 | Dec 31, 2014 | $22.59M | +73.7% |
| FY2013 | Dec 31, 2013 | $13.01M | +123.8% |
| FY2012 | Dec 31, 2012 | $5.81M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$14.71M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.65M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.43M | – |
| Q4 FY2025 | Dec 31, 2025 | $2.30M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.91M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$23.84M | – |
| Q3 FY2023 | Sep 30, 2023 | -$42.31M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.51M | -1014.0% |
| Q1 FY2023 | Mar 31, 2023 | -$17.83M | – |
| Q4 FY2022 | Dec 31, 2022 | -$52.51M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.51M | -166.9% |
| Q2 FY2022 | Jun 30, 2022 | $822.00K | -94.4% |
| Q1 FY2022 | Mar 31, 2022 | -$7.83M | -363.9% |
| Q4 FY2021 | Dec 31, 2021 | -$906.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $9.74M | +1912.6% |
| Q2 FY2021 | Jun 30, 2021 | $14.71M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.97M | +29.9% |
| Q4 FY2020 | Dec 31, 2020 | -$595.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $484.00K | -95.4% |
| Q2 FY2020 | Jun 30, 2020 | -$121.00K | -100.8% |
| Q1 FY2020 | Mar 31, 2020 | $2.28M | -70.2% |
| Q4 FY2019 | Dec 31, 2019 | -$703.00K | -109.3% |
| Q3 FY2019 | Sep 30, 2019 | $10.50M | -17.8% |
| Q2 FY2019 | Jun 30, 2019 | $14.58M | -11.8% |
| Q1 FY2019 | Mar 31, 2019 | $7.65M | -34.6% |
| Q4 FY2018 | Dec 31, 2018 | $7.55M | -8.3% |
| Q3 FY2018 | Sep 30, 2018 | $12.78M | +14.4% |
| Q2 FY2018 | Jun 30, 2018 | $16.54M | +43.9% |
| Q1 FY2018 | Mar 31, 2018 | $11.69M | +33.3% |
| Q4 FY2017 | Dec 31, 2017 | $8.24M | -12.8% |
| Q3 FY2017 | Sep 30, 2017 | $11.17M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.78M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.44M | – |
See a number that looks wrong?